Amedisys

Amedisys, Inc. engages in the provision of healthcare services. It operates through the following business segments: Home Health, Hospice, and Personal Care. The Home Health segment delivers services in the homes of individuals who may be recovering from an illness, injury, or surgery. The Hospice segment provides care that is designed to provide comfort and support for those who are facing a terminal illness. The Personal Care segment gives patients assistance with the essential activities of daily living. The company was founded by William F. Borne in 1982 and is headquartered in Baton Rouge, LA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Amedisys reports robust Q4 earnings, eyes growth amidst operational challenges

Amedisys showcases strong financial performance and strategic initiatives for 2023, focusing on growth and operational optimization.
Despite challenges like labor market issues and operational hurdles, the company remains confident in its growth strategies and talent management.
Opportunities in negotiations with payers, talent acquisition, and operational enhancements position Amedisys for continued success and revenue growth.
With a positive outlook for 2023 and a resilient approach to challenges, Amedisys is poised for steady growth and operational improvements.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Amedisys, Inc. engages in the provision of healthcare services. It operates through the following business segments: Home Health, Hospice, Personal Care, and High Acuity Care. The Home Health segment delivers services in the homes of individuals who may be recovering from an illness, injury, or surgery. The Hospice segment provides care that is designed to provide comfort and support for those who are facing a terminal illness. The Personal Care segment gives patients assistance with the essential activities of daily living. The High Acuity Care segment includes providing home care recovery for high acuity patients on either a full risk or limited risk basis. The company was founded in 1982 and is headquartered in Baton Rouge, LA.

BATON ROUGE, La., July 06, 2022 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of quality home health, hospice, personal care and high-acuity care, will report results for the second quarter ended June 30, 2022, after the market closes on July 27, 2022. The Company will host an investor conference call to discuss these results at 11:00 a.m. ET on July 28, 2022.

Amedisys Announces Second Quarter 2022 Earnings Release and Conference Call Date

Amedisys (AMED) strengthens its Home Health and Hospice business reach by partnering with Memorial Hermann.

Amedisys' (AMED) New Tie Up to Boost At-Home Patient Care

This partnership gives patients options of where to receive inpatient, rehabilitation, and palliative care This partnership gives patients options of where to receive inpatient, rehabilitation, and palliative care

Memorial Hermann and Contessa Partner to Provide Patients New At-Home Care Options

Amedisys' (AMED) latest initiative aims at providing patients with a high-quality continuum of care in the home.

Amedisys (AMED) Contessa's New JV Broadens At-Home Care Range

Partnership will create a continuum of at-home care that encourages patient choice, reduces costs and improves outcomes Partnership will create a continuum of at-home care that encourages patient choice, reduces costs and improves outcomes

Baylor Scott & White Health and Contessa Announce Partnership to Create New Model of At-Home Care for Patients

BATON ROUGE, La., June 09, 2022 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice, personal care and high-acuity care, has released its first Environmental, Social and Governance (ESG) Report for the year 2021, detailing actions, achievements and goals in each critical area.

Amedisys Releases Inaugural Environmental, Social and Governance (ESG) Report

Amedisys (AMED) reported earnings 30 days ago. What's next for the stock?

Amedisys (AMED) Down 11% Since Last Earnings Report: Can It Rebound?

BATON ROUGE, La., May 25, 2022 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice, personal care and high-acuity care, today announced that Chris Gerard, President and Chief Executive Officer and Scott Ginn, Executive Vice President and Chief Financial Officer, will present and conduct investor one-on-ones at the Benchmark Healthcare House Calls Conference on Thursday, June 2, the William Blair 42nd Annual Growth Stock Conference on Monday, June 6 at 2 p.m. CST and the Jefferies Healthcare Conference on Wednesday, June 8 from 3:30-3:55 p.m. ET.

Amedisys to Present at Multiple Healthcare Conferences in June

Amedisys' (AMED) newly-formed high-acuity care segment experiences solid momentum in the first quarter.

Amedisys (AMED) New Buyouts Aid Growth, Margin Pressure Stays

BATON ROUGE, La., May 06, 2022 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice, personal care, palliative and high-acuity care, celebrates National Nurses Week by honoring the thousands of nurses who call the company home.

Amedisys Celebrates National Nurses Week

BATON ROUGE, La., April 29, 2022 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice, personal care and high-acuity care, today announced that Chris Gerard, President and Chief Executive Officer, and Scott Ginn, Executive Vice President and Chief Financial Officer, will present and conduct investor one on ones at the Bank of America Securities 2022 Healthcare Conference on Tuesday, May 10, at 5:40 p.m. ET, the 2022 RBC Capital Markets Global Healthcare Conference on Tuesday, May 17, and the UBS Global Healthcare Conference on Monday, May 23, at 9:15 a.m. ET.

Amedisys to Present at Multiple Healthcare Conferences in May

Amedisys, Inc. (NASDAQ:AMED ) Q1 2022 Earnings Conference Call April 28, 2022 11:00 AM ET Company Participants Nick Muscato - Chief Strategy Officer Christopher Gerard - CEO, President & Director Scott Ginn - EVP & CFO David Kemmerly - Chief Legal & Government Affairs Officer Conference Call Participants Brian Tanquilut - Jefferies Matthew Larew - William Blair & Company Justin Bowers - Deutsche Bank John Ransom - Raymond James & Associates Matthew Borsch - BMO Capital Markets Andrew Mok - UBS Benjamin Mayo - SVB Leerink Sarah James - Barclays Bank Joanna Gajuk - Bank of America Merrill Lynch Albert Rice - Crédit Suisse Operator Greetings, and welcome to Amedisys' Q1 '22 Earnings Conference Call. [Operator Instructions].

Amedisys, Inc. (AMED) CEO Christopher Gerard on Q1 2022 Results - Earnings Call Transcript

Impressive performance by the Home Health and Hospice segments drove Amedisys' (AMED) revenues in the first quarter.

Amedisys (AMED) Q1 Earnings Surpass Estimates, Margins Down

BATON ROUGE, La., April 27, 2022 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three-month period ended March 31, 2022.

Amedisys Reports First Quarter 2022 Financial Results and Reaffirms 2022 Guidance

BATON ROUGE, La., April 13, 2022 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of quality home health, hospice, personal care and high-acuity care, will report results for the first quarter ended March 31, 2022, after the market closes on April 27, 2022. The Company will host an investor conference call to discuss these results at 11:00 a.m. ET on April 28, 2022.

Amedisys Announces First Quarter 2022 Earnings Release and Conference Call Date

Investors are optimistic about Amedisys' (AMED) strong segmental performance and strategic buyouts.

Here's Why You Should Retain Amedisys (AMED) Stock For Now

BATON ROUGE, La., April 04, 2022 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of quality home health, hospice, personal care and high-acuity care, has closed on its acquisition of Evolution Health, LLC, a provider of home health services. Evolution Health, LLC, a division of Envision Healthcare, is doing business as Guardian Healthcare, Gem City, and Care Connection of Cincinnati in 15 locations across Texas, Oklahoma and Ohio. Amedisys has acquired 100 percent of the ownership interests in Evolution Health.

Amedisys Completes Acquisition of Evolution Health

BATON ROUGE, La., April 04, 2022 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of quality home health, hospice, personal care and high-acuity care, has closed on its acquisition of certain home health assets from AssistedCare Home Health, Inc., and RH Homecare Services, LLC, doing business as AssistedCare Home Health and AssistedCare of the Carolinas, respectively.

Amedisys Completes Acquisition of Home Health Assets from AssistedCare Home Health and AssistedCare of the Carolinas

Why Is Amedisys (AMED) Up 13.2% Since Last Earnings Report?

BATON ROUGE, La., Feb. 28, 2022 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice, personal care and high-acuity care services, today announced that Chris Gerard, President and Chief Operating Officer and Scott Ginn, Executive Vice President and Chief Financial Officer, will present at the Raymond James & Associates' 43rd Annual Institutional Investors Conference on Tuesday, March 8, at 11:35 a.m. EST.

Amedisys to Present at the Raymond James & Associates' 43rd Annual Institutional Investors Conference

Amedisys, Inc. (AMED) CEO Paul Kusserow on Q4 2021 Results - Earnings Call Transcript

Robust performances by the Home Health and Hospice segments drove Amedisys' (AMED) fourth-quarter top line.

Amedisys (AMED) Q4 Earnings Top Estimates, Margins Decline

Amedisys (AMED) delivered earnings and revenue surprises of 0.86% and 0.73%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Amedisys (AMED) Beats Q4 Earnings and Revenue Estimates

BATON ROUGE, La., Feb. 23, 2022 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three-month period and year ended December 31, 2021.

News for Amedisys Stock (AMED)